Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tern plc ( (GB:TERN) ) just unveiled an announcement.
Tern Plc has been issued approximately £230,000 in new unsecured convertible loan notes by Talking Medicines Limited, in exchange for canceling existing short-term loans totaling about £180,000. This move increases Tern’s total convertible loan note holding in Talking Medicines to approximately £0.52 million while maintaining its 23.8% equity stake. Talking Medicines is raising up to £1.0 million through similar convertible loan notes to enhance its capabilities in the healthcare advertising market, which it aims to revolutionize with advanced data science and AI.
The most recent analyst rating on (GB:TERN) stock is a Hold with a £0.63 price target. To see the full list of analyst forecasts on Tern plc stock, see the GB:TERN Stock Forecast page.
Spark’s Take on GB:TERN Stock
According to Spark, TipRanks’ AI Analyst, GB:TERN is a Neutral.
Tern plc’s overall stock score is primarily impacted by its significant financial challenges, including declining revenue and negative profitability. Technical analysis provides some short-term bullish signals, but overbought conditions pose risks. Poor valuation metrics further weigh on the score, highlighting the need for improved earnings and strategic initiatives.
To see Spark’s full report on GB:TERN stock, click here.
More about Tern plc
Tern Plc is an investment company that focuses on supporting high growth, early-stage, disruptive Internet of Things (IoT) technology businesses.
Average Trading Volume: 3,205,236
Technical Sentiment Signal: Sell
Current Market Cap: £3.36M
For detailed information about TERN stock, go to TipRanks’ Stock Analysis page.